These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25108300)
1. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide. Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649 [TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners. Matveenko M; Banwell MG; Joffe M; Wan S; Fantino E Chem Biodivers; 2009 May; 6(5):685-91. PubMed ID: 19479847 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives. Ghavre M; Froese J; Pour M; Hudlicky T Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844 [TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies. Pettit GR; Tan R; Bao GH; Melody N; Doubek DL; Gao S; Chapuis JC; Williams L J Nat Prod; 2012 Apr; 75(4):771-3. PubMed ID: 22413911 [TBL] [Abstract][Full Text] [Related]
6. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Kornienko A; Evidente A Chem Rev; 2008 Jun; 108(6):1982-2014. PubMed ID: 18489166 [No Abstract] [Full Text] [Related]
7. Novel lycorine derivatives as anticancer agents: synthesis and in vitro biological evaluation. Wang P; Yuan HH; Zhang X; Li YP; Shang LQ; Yin Z Molecules; 2014 Feb; 19(2):2469-80. PubMed ID: 24566315 [TBL] [Abstract][Full Text] [Related]
8. Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine. Goulart Stollmaier J; Thomson J; Endoma-Arias MA; Simionescu R; Vernaza A; Mesa-Diaz N; Smith M; Du L; Kornienko A; Hudlicky T Molecules; 2022 Jun; 27(13):. PubMed ID: 35807391 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimalarial activity of new haemanthamine-type derivatives. Cedrón JC; Gutiérrez D; Flores N; Ravelo ÁG; Estévez-Braun A Bioorg Med Chem; 2012 Sep; 20(18):5464-72. PubMed ID: 22910226 [TBL] [Abstract][Full Text] [Related]
10. Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives. Hudlicky T; Rinner U; Gonzalez D; Akgun H; Schilling S; Siengalewicz P; Martinot TA; Pettit GR J Org Chem; 2002 Dec; 67(25):8726-43. PubMed ID: 12467383 [TBL] [Abstract][Full Text] [Related]
11. Total Synthesis of Lycoricidine and Narciclasine by Chemical Dearomatization of Bromobenzene. Southgate EH; Holycross DR; Sarlah D Angew Chem Int Ed Engl; 2017 Nov; 56(47):15049-15052. PubMed ID: 29024240 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation. Vshyvenko S; Scattolon J; Hudlicky T; Romero AE; Kornienko A Bioorg Med Chem Lett; 2011 Aug; 21(16):4750-2. PubMed ID: 21757350 [TBL] [Abstract][Full Text] [Related]
13. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells. Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754 [TBL] [Abstract][Full Text] [Related]
14. In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives. Evdokimov NM; Lamoral-Theys D; Mathieu V; Andolfi A; Frolova LV; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Kornienko A Bioorg Med Chem; 2011 Dec; 19(23):7252-61. PubMed ID: 22019045 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiplasmodial activity of lycorine derivatives. Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737 [TBL] [Abstract][Full Text] [Related]
19. (±)-trans-Dihydronarciclasine and (±)-trans-dihydrolycoricidine analogues modified in their ring A: Evaluation of their anticancer activity and a SAR study. Varró G; Pálchuber P; Pogrányi B; Simon A; Hegedűs L; Kádas I Eur J Med Chem; 2019 Jul; 173():76-89. PubMed ID: 30986573 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies. Santhosh Kumar G; Poornachandra Y; Kumar Gunda S; Ratnakar Reddy K; Mohmed J; Shaik K; Ganesh Kumar C; Narsaiah B Bioorg Med Chem Lett; 2018 Jul; 28(13):2328-2337. PubMed ID: 29798826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]